Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Eradacil
Synonyms :
rosoxacin
Class :
Quinolones
Brand Name :
Eradacil
Synonyms :
rosoxacin
Class :
Quinolones
Dosage Forms & StrengthsÂ
Capsule Â
300 mg Â
Take a dose of 300 mg orally as a single dose
Not determined Â
Refer to adult dosingÂ
rosoxacin: it may increase the risk of QTc prolongation agents
rosoxacin: it may increase the risk of QTc prolongation agents
rosoxacin: it may increase the risk of QTc prolongation agents
rosoxacin: it may increase the risk of QTc prolongation agents
rosoxacin: it may increase the risk of QTc prolongation agents
when combined with rosoxacin, metabolism of bufylline may be reduced
amoxicillin: it may increase the serum concentration of rosoxacin
ampicillin: it may increase the serum concentration of rosoxacin
anagrelide: it may decrease the metabolism of rosoxacin
antipyrine: it may decrease the metabolism of rosoxacin
antrafenine: it may increase the neuroexcitatory activities of rosoxacin
bendamustine: it may decrease the metabolism of rosoxacin
benorilate: it may increase the neuroexcitatory activities of rosoxacin
Actions and SpectrumÂ
The enzymes topoisomerase II (DNA gyrase) and topoisomerase IV, which are necessary for bacterial DNA replication, transcription, repair, and recombination are bound by rosoxacin and inhibited by it.
Frequency not defined Â
Hypersensitivity reactionsÂ
Neurological effectsÂ
Toxic psychoses or convulsions Â
Skin reactionsÂ
Tendon damage Â
NauseaÂ
VomitingÂ
DiarrheaÂ
Abdominal painÂ
Hepatic effects
Black Box WarningÂ
None Â
Contraindication/Caution:Â
Contraindication:Â
Caution:Â
Pregnancy consideration:Â
Pregnancy category: N/AÂ
Lactation: Excretion into human milk is unknown Â
Pregnancy Categories:        Â
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.Â
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women. Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.Â
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.Â
Category N: There is no data available for the drug under this category.Â
Pharmacology Â
rosoxacin is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria. It has actions like nalidixic acid and active against Neisseria gonorrhoeae.Â
PharmacodynamicsÂ
The antibiotic rosoxacin is a nonfluorinated quinolone. By attaching itself to the enzyme DNA gyrase, it prevents the replication of bacterial DNA, which is how it works.Â
PharmacokineticsÂ
Limited information on ADME.Â
AdministrationÂ
rosoxacin is available in the form of capsule for oral intake. Â
Patient information leafletÂ
Generic Name: rosoxacinÂ
Why do we use rosoxacin?Â
rosoxacin is used in the treatment of bacterial infection of respiratory and urinary tract.  Â
rosoxacin is used in the treatment of uncomplicated gonorrhoea.Â
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
